ClinicalTrials.Veeva

Menu

Leipzig Adipose Tissue Childhood Cohort

U

University of Leipzig

Status

Enrolling

Conditions

Insulin Resistance
Childhood Obesity

Study type

Observational

Funder types

Other

Identifiers

NCT02208141
IFB ADI K7-10

Details and patient eligibility

About

In this study the investigators hypothesize that pathological alterations in adipose tissue biology already occur during the development and progression of obesity in children and adolescents. The investigators aim to identify and characterize mechanisms and molecular targets that affect the development of adipose tissue and ensuing obesity in childhood and adolescence.

Full description

The investigators aim to identify how adipose tissue dysfunction in childhood contributes to the development of obesity and related comorbidities and to characterize factors that play a role in the development of adipose dysfunction in children. The investigators will employ a translational approach which is based on the characterization of adipose tissue biology in samples of children to determine alterations leading to adipose tissue dysfunction. These include assessment of the composition (including BAT), remodeling, function, metabolism and inflammation of adipose tissue as well as the adipokine profile. For the assessment of clinical relevance, these experimental data will then be correlated with the clinical phenotype. Finally, we aim to identify factors responsible for early adipose tissue dysfunction and characterize them for their clinical and functional relevance.

Enrollment

1,000 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • body weight: 3000 g - 180 kg
  • suitable surgical procedure
  • signed informed consent by the guardians and the study participant, if older 12 years

Exclusion criteria

  • severe chronic and inflammatory diseases
  • acute or chronic infections
  • oncological diseases
  • clotting disorders
  • complications during surgical procedure
  • drug treatment
  • nil by mouth

Trial design

1,000 participants in 1 patient group

lean and obese children and adolescents
Description:
study cohort may be stratified for lean (definded as BMI \<1.28 SDS) and overweight/obese (definded as BMI\>= 1.28 SDS) children for posthoc analyses no intervention

Trial contacts and locations

1

Loading...

Central trial contact

Robert Stein, MD; Antje Körner, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems